Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines

F. Passiglia, S. Pilotto, F. Facchinetti, L. Bertolaccini, M. Del Re, R. Ferrara, T. Franchina, U. Malapelle, J. Menis, A. Passaro, S. Ramella, G. Rossi, Rocco Trisolini, S. Novello*

*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivistaArticolo

Abstract

The Italian Association of Medical Oncology (AIOM) has developed clinical practice guidelines for the treatment of patients with advanced non-small cell lung cancer (NSCLC). In the current paper a panel of AIOM experts in the field of thoracic malignancies discussed the available scientific evidences, with the final aim of providing a summary of clinical recommendations, which may guide physicians in their current practice.
Lingua originaleInglese
pagine (da-a)102858-102861
Numero di pagine4
RivistaCritical Reviews in Oncology/Hematology
Volume146
Numero di pubblicazione2020
DOI
Stato di pubblicazionePubblicato - 2020

All Science Journal Classification (ASJC) codes

  • Ematologia
  • Oncologia
  • Geriatria e Gerontologia

Keywords

  • Clinical practice guidelines
  • Metastatic disease
  • Non-small cell lung cancer
  • Recommendations
  • non-small-cell lung cancer

Fingerprint

Entra nei temi di ricerca di 'Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines'. Insieme formano una fingerprint unica.

Cita questo